BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37713318)

  • 1. Serum brain-derived neurotrophic factor levels as a predictor for Alzheimer disease progression.
    Tsai MJ; Lin YS; Chen CY; Lee WJ; Fuh JL
    J Chin Med Assoc; 2023 Nov; 86(11):960-965. PubMed ID: 37713318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients.
    Laske C; Stellos K; Hoffmann N; Stransky E; Straten G; Eschweiler GW; Leyhe T
    Int J Neuropsychopharmacol; 2011 Apr; 14(3):399-404. PubMed ID: 20860877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apathy and APOE4 are associated with reduced BDNF levels in Alzheimer's disease.
    Alvarez A; Aleixandre M; Linares C; Masliah E; Moessler H
    J Alzheimers Dis; 2014; 42(4):1347-55. PubMed ID: 25024337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis.
    Kim BY; Lee SH; Graham PL; Angelucci F; Lucia A; Pareja-Galeano H; Leyhe T; Turana Y; Lee IR; Yoon JH; Shin JI
    Mol Neurobiol; 2017 Nov; 54(9):7297-7311. PubMed ID: 27815832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis.
    Ng TKS; Ho CSH; Tam WWS; Kua EH; Ho RC
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.
    Peng S; Wuu J; Mufson EJ; Fahnestock M
    J Neurochem; 2005 Jun; 93(6):1412-21. PubMed ID: 15935057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage-dependent BDNF serum concentrations in Alzheimer's disease.
    Laske C; Stransky E; Leyhe T; Eschweiler GW; Wittorf A; Richartz E; Bartels M; Buchkremer G; Schott K
    J Neural Transm (Vienna); 2006 Sep; 113(9):1217-24. PubMed ID: 16362629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease.
    Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kawamura S; Agawa-Ohta M; Kasahara H; Nakayama K; Yamada H
    Psychogeriatrics; 2011 Sep; 11(3):141-9. PubMed ID: 21951954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between Brain-Derived Neurotrophic Factor and Cognitive Decline in Patients with Mild Cognitive Impairment and Dementia.
    Nikolac Perkovic M; Borovecki F; Filipcic I; Vuic B; Milos T; Nedic Erjavec G; Konjevod M; Tudor L; Mimica N; Uzun S; Kozumplik O; Svob Strac D; Pivac N
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations Between ApoEε4 Carrier Status and Serum BDNF Levels--New Insights into the Molecular Mechanism of ApoEε4 Actions in Alzheimer's Disease.
    Liu YH; Jiao SS; Wang YR; Bu XL; Yao XQ; Xiang Y; Wang QH; Wang L; Deng J; Li J; Zhou XF; Zhou HD; Wang YJ
    Mol Neurobiol; 2015; 51(3):1271-7. PubMed ID: 24986007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction Between BDNF Val66Met and APOE4 on Biomarkers of Alzheimer's Disease and Cognitive Decline.
    Stonnington CM; Velgos SN; Chen Y; Syed S; Huentelman M; Thiyyagura P; Lee W; Richholt R; Caselli RJ; Locke DEC; Lu B; Reiman EM; Su Y; Chen K
    J Alzheimers Dis; 2020; 78(2):721-734. PubMed ID: 33044176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer's disease cases.
    O'Bryant SE; Hobson VL; Hall JR; Barber RC; Zhang S; Johnson L; Diaz-Arrastia R;
    Dement Geriatr Cogn Disord; 2011; 31(1):31-6. PubMed ID: 21135555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of hippocampal volume and serum brain-derived neurotrophic factor as potential diagnostic markers of conversion from amnestic mild cognitive impairment to Alzheimer disease: A STROBE-compliant article.
    Fang Y; Du N; Xing L; Duo Y; Zheng L
    Medicine (Baltimore); 2019 Jul; 98(30):e16604. PubMed ID: 31348306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.
    Cechova K; Andel R; Angelucci F; Chmatalova Z; Markova H; Laczó J; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Ward DD; Hort J
    J Alzheimers Dis; 2020; 73(1):247-257. PubMed ID: 31771052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects.
    Forlenza OV; Miranda AS; Guimar I; Talib LL; Diniz BS; Gattaz WF; Teixeira AL
    J Alzheimers Dis; 2015; 46(2):423-9. PubMed ID: 25737042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene- and Gender-Related Decrease in Serum BDNF Levels in Alzheimer's Disease.
    Piancatelli D; Aureli A; Sebastiani P; Colanardi A; Del Beato T; Del Cane L; Sucapane P; Marini C; Di Loreto S
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
    Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
    Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Boots EA; Schultz SA; Clark LR; Racine AM; Darst BF; Koscik RL; Carlsson CM; Gallagher CL; Hogan KJ; Bendlin BB; Asthana S; Sager MA; Hermann BP; Christian BT; Dubal DB; Engelman CD; Johnson SC; Okonkwo OC
    Neurology; 2017 May; 88(22):2098-2106. PubMed ID: 28468845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced plasma BDNF concentration and cognitive decline in veterans with PTSD.
    Domitrovic Spudic S; Nikolac Perkovic M; Uzun S; Nedic Erjavec G; Kozumplik O; Svob Strac D; Mimica N; Pivac N
    Psychiatry Res; 2022 Oct; 316():114772. PubMed ID: 35961151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BDNF VAL66MET polymorphism and memory decline across the spectrum of Alzheimer's disease.
    Lim YY; Laws SM; Perin S; Pietrzak RH; Fowler C; Masters CL; Maruff P;
    Genes Brain Behav; 2021 Jun; 20(5):e12724. PubMed ID: 33369083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.